That means they have been compounding medications for four decades, long before semaglutide existed, long before GLP-1 receptor agonists became household terms, and long before the weight loss medication market turned into what it is today
Inequities in access and adherence to effective treatments have the potential to exacerbate disparities in obesity. GLP-1 Side Effects Lawsuits The two studies come as more than 1,300 lawsuits are currently being pursued against the makers of Ozempic, Wegovy, Mounjaro and other similar diabetes and weight loss drugs, each raising similar allegations that a desire for increased profits was placed above consumer safety by failing to research and disclose gastroparesis side effects users may experience
Eden Health has paused its compounded GLP-1 program (both semaglutide and tirzepatide) for new patient enrollment as of mid-2026
How can clinicians reduce retinopathy risk during treatment
Interested in more guidance
Weight loss varies by medical history, medication, dose, nutrition, activity, adherence, and side effects
